VISTA, IDO1, and PD-L1 are key immune checkpoints, with VISTA and IDO1 appearing more abundant in the stromal compartment of primary tumors, whereas PD-L1 indicated higher expression in their respective tumor compartments. The gene discussed is IDO1; the disease is neoplasm.